Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older.

Working to Develop a More Safe and Convenient Treatment Option for Patients with Rare Platelet Disorder

Immune thrombocytopenia (ITP) is a lesser-known bleeding disorder that severely impacts patients’ quality of life.

Cancer Doesn't Wait: Why People Need to Get Back to Cancer Screenings and Follow-up Appointments

Around the country, doctors and healthcare systems are reporting an alarming drop in non-COVID-19 patient visits.

Coronavirus COVID-19 Resource Center

As the coronavirus disease (COVID-19) continues to spread, at Pfizer, we are committed to ensuring public health and safety for our colleagues, retirees, and global patient community. Learn more about COVID-19 and what you can do to stay safe and prevent the spread of this infectious disease.

Join the Pfizer Plus Community Corner

When you join the PfizerPlus.com community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • PfizerPlus.com Community